GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » ROE % Adjusted to Book Value

Statera BioPharma (STU:7CB) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma ROE % Adjusted to Book Value?

Statera BioPharma's ROE % for the quarter that ended in Sep. 2022 was 0.00%. Statera BioPharma's PB Ratio for the quarter that ended in Sep. 2022 was N/A. Statera BioPharma's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2022 was N/A.


Statera BioPharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Statera BioPharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma ROE % Adjusted to Book Value Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
ROE % Adjusted to Book Value
- - -

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Statera BioPharma's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Statera BioPharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Statera BioPharma's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's ROE % Adjusted to Book Value falls into.



Statera BioPharma ROE % Adjusted to Book Value Calculation

Statera BioPharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Statera BioPharma's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Statera BioPharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Statera BioPharma Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma Headlines

No Headlines